ATEC Quote, Financials, Valuation and Earnings

Baxter International has a net margin of -30.68% compared to Alphatec Holdings's net margin of 4.8%. Alphatec Holdings's return on equity of -691.37% beat Baxter International's return on equity of -7.38%.

Alphatec Holdings has a consensus price target of $18.32, signalling upside risk potential of 47.13%. On the other hand Baxter International has an analysts' consensus of $38.68 which suggests that it could grow by 28.41%. Given that Alphatec Holdings has higher upside potential than Baxter International, analysts believe Alphatec Holdings is more attractive than Baxter International.

Alphatec Holdings has a beta of 1.062, which suggesting that the stock is 6.249% more volatile than S&P 500. In comparison Baxter International has a beta of 0.628, suggesting its less volatile than the S&P 500 by 37.167%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Baxter International offers a yield of 3.05% to investors and pays a quarterly dividend of $0.17 per share. Alphatec Holdings pays -- of its earnings as a dividend. Baxter International pays out -90.91% of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $169.2M, which are smaller than Baxter International quarterly revenues of $2.6B. Alphatec Holdings's net income of -$51.9M is lower than Baxter International's net income of $126M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Baxter International's PE ratio is 167.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.80x versus 1.30x for Baxter International. Usually stocks with elevated PS ratios are considered overvalued.

Becton Dickinson & has a net margin of -30.68% compared to Alphatec Holdings's net margin of 5.84%. Alphatec Holdings's return on equity of -691.37% beat Becton Dickinson &'s return on equity of 5.86%.

Alphatec Holdings has a consensus price target of $18.32, signalling upside risk potential of 47.13%. On the other hand Becton Dickinson & has an analysts' consensus of $222.96 which suggests that it could grow by 30.1%. Given that Alphatec Holdings has higher upside potential than Becton Dickinson &, analysts believe Alphatec Holdings is more attractive than Becton Dickinson &.

Alphatec Holdings has a beta of 1.062, which suggesting that the stock is 6.249% more volatile than S&P 500. In comparison Becton Dickinson & has a beta of 0.312, suggesting its less volatile than the S&P 500 by 68.788%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Becton Dickinson & offers a yield of 2.32% to investors and pays a quarterly dividend of $1.04 per share. Alphatec Holdings pays -- of its earnings as a dividend. Becton Dickinson & pays out 64.52% of its earnings as a dividend. Becton Dickinson &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alphatec Holdings quarterly revenues are $169.2M, which are smaller than Becton Dickinson & quarterly revenues of $5.3B. Alphatec Holdings's net income of -$51.9M is lower than Becton Dickinson &'s net income of $308M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Becton Dickinson &'s PE ratio is 32.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.80x versus 2.38x for Becton Dickinson &. Usually stocks with elevated PS ratios are considered overvalued.

Globus Medical has a net margin of -30.68% compared to Alphatec Holdings's net margin of 12.62%. Alphatec Holdings's return on equity of -691.37% beat Globus Medical's return on equity of 4.59%.

Alphatec Holdings has a consensus price target of $18.32, signalling upside risk potential of 47.13%. On the other hand Globus Medical has an analysts' consensus of $85.17 which suggests that it could grow by 44.45%. Given that Alphatec Holdings has higher upside potential than Globus Medical, analysts believe Alphatec Holdings is more attractive than Globus Medical.

Alphatec Holdings has a beta of 1.062, which suggesting that the stock is 6.249% more volatile than S&P 500. In comparison Globus Medical has a beta of 1.324, suggesting its more volatile than the S&P 500 by 32.371%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Globus Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings pays -- of its earnings as a dividend. Globus Medical pays out -- of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $169.2M, which are smaller than Globus Medical quarterly revenues of $598.1M. Alphatec Holdings's net income of -$51.9M is lower than Globus Medical's net income of $75.5M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Globus Medical's PE ratio is 44.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.80x versus 3.26x for Globus Medical. Usually stocks with elevated PS ratios are considered overvalued.

Orthofix Medical has a net margin of -30.68% compared to Alphatec Holdings's net margin of -27.42%. Alphatec Holdings's return on equity of -691.37% beat Orthofix Medical's return on equity of -27.48%.

Alphatec Holdings has a consensus price target of $18.32, signalling upside risk potential of 47.13%. On the other hand Orthofix Medical has an analysts' consensus of $24.40 which suggests that it could grow by 119.82%. Given that Orthofix Medical has higher upside potential than Alphatec Holdings, analysts believe Orthofix Medical is more attractive than Alphatec Holdings.

Alphatec Holdings has a beta of 1.062, which suggesting that the stock is 6.249% more volatile than S&P 500. In comparison Orthofix Medical has a beta of 0.872, suggesting its less volatile than the S&P 500 by 12.792%.

Alphatec Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Orthofix Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alphatec Holdings pays -- of its earnings as a dividend. Orthofix Medical pays out -- of its earnings as a dividend.

Alphatec Holdings quarterly revenues are $169.2M, which are smaller than Orthofix Medical quarterly revenues of $193.6M. Alphatec Holdings's net income of -$51.9M is higher than Orthofix Medical's net income of -$53.1M. Notably, Alphatec Holdings's price-to-earnings ratio is -- while Orthofix Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alphatec Holdings is 2.80x versus 0.53x for Orthofix Medical. Usually stocks with elevated PS ratios are considered overvalued.